See more : Tetra Tech, Inc. (TTEK) Income Statement Analysis – Financial Results
Complete financial analysis of Biome Grow Inc. (BIO.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Biome Grow Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- W World Corp. (WWHC) Income Statement Analysis – Financial Results
- ZIVO Bioscience, Inc. (ZIVOW) Income Statement Analysis – Financial Results
- Synthetic Biologics, Inc. (SYN) Income Statement Analysis – Financial Results
- Grupo Industrial Saltillo, S.A.B. de C.V. (GISSAA.MX) Income Statement Analysis – Financial Results
- Kao Corporation (KAOOY) Income Statement Analysis – Financial Results
Biome Grow Inc. (BIO.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.biomegrow.com
About Biome Grow Inc.
Biome Grow Inc. focuses on the cannabis business. The company is headquartered in Toronto, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 4.68M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 3.55M | 1.68M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 1.13M | -1.68M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 24.22% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 107.13K | 0.00 | 0.00 | 2.49M | 0.00 |
| General & Administrative | 406.45K | 1.06M | 3.84M | 4.28M | 8.64M | 59.45K | 705.79K | 1.29M | 470.06K |
| Selling & Marketing | 203.20K | 0.00 | 7.64K | 786.91K | 810.55K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 609.65K | 1.06M | 3.85M | 5.07M | 9.45M | 59.45K | 705.79K | 1.29M | 470.06K |
| Other Expenses | 0.00 | 0.00 | -275.47K | 152.54K | 113.69K | 0.00 | 0.00 | 9.33K | 0.00 |
| Operating Expenses | 609.65K | 1.06M | 3.85M | 5.22M | 9.82M | 59.45K | 705.79K | 3.79M | 470.06K |
| Cost & Expenses | 609.65K | 1.06M | 3.85M | 8.77M | 9.82M | 59.45K | 705.79K | 3.79M | 470.06K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 352.40K | 453.54K | 1.84M | 62.05K | 0.00 | 0.00 | 0.00 | 253.00 | 4.33K |
| Depreciation & Amortization | 0.00 | 1.01M | 115.18K | 115.18K | 260.32K | 791.97K | 337.75K | 9.33K | 0.00 |
| EBITDA | 0.00 | 0.00 | -4.06M | -9.05M | -8.60M | 0.00 | -368.03K | -3.78M | -470.06K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | -79.20% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -609.65K | -1.06M | -4.12M | -4.01M | -9.70M | -59.45K | -705.79K | -3.79M | -470.06K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | -85.63% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -10.28M | 870.05K | 2.46M | -4.69M | -2.78M | -35.63K | 705.72K | 253.00 | -4.33K |
| Income Before Tax | -10.89M | -139.93K | -1.72M | -9.75M | -8.86M | 185.61K | -1.04M | -3.79M | -474.40K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | -208.29% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 453.54K | 86.44K | -265.00K | -841.85K | -245.06K | 337.75K | -505.00 | 0.00 |
| Net Income | -10.89M | -593.47K | -1.80M | -9.48M | -8.86M | 185.61K | -1.04M | -3.79M | -474.40K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | -202.62% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.10 | -0.01 | -0.02 | -0.09 | -0.09 | 0.16 | -0.94 | -4.22 | -0.71 |
| EPS Diluted | -0.10 | -0.01 | -0.02 | -0.09 | -0.09 | 0.16 | -0.94 | -4.22 | -0.71 |
| Weighted Avg Shares Out | 112.42M | 112.42M | 111.89M | 110.57M | 102.27M | 1.14M | 1.10M | 897.81K | 663.66K |
| Weighted Avg Shares Out (Dil) | 112.42M | 112.42M | 111.89M | 110.57M | 102.27M | 1.14M | 1.10M | 897.81K | 663.66K |
No news found for: BIO.CN
Source: https://incomestatements.info
Category: Stock Reports